547 related articles for article (PubMed ID: 26897028)
21. BCL11A-targeted γ-globin gene induction by triterpenoid glycosides of Fagonia indica: A preclinical scientific validation of indigenous herb for the treatment of β-hemoglobinopathies.
Iftikhar F; Khan MBN; Tehreem S; Kanwal N; Musharraf SG
Bioorg Chem; 2023 Nov; 140():106768. PubMed ID: 37586133
[TBL] [Abstract][Full Text] [Related]
22. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
[TBL] [Abstract][Full Text] [Related]
23. Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.
Macari ER; Lowrey CH
Blood; 2011 Jun; 117(22):5987-97. PubMed ID: 21464371
[TBL] [Abstract][Full Text] [Related]
24. The relationship between the variations in Gγ and Aγ promotors and the Hereditary Persistence of Fetal Hemoglobin (HPFH).
Aydin M; Rencuzogullari E; Dalyan A; Bayram S; Genc A
Cell Mol Biol (Noisy-le-grand); 2018 Jan; 64(1):32-39. PubMed ID: 29412791
[TBL] [Abstract][Full Text] [Related]
25. Functional Analysis of an (A)γ-Globin Gene Promoter Variant (HBG1: g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress.
Ugrin M; Stojiljkovic M; Zukic B; Klaassen K; Katsila T; Vasiljevic J; Dokmanovic L; Janic D; Patrinos GP; Pavlovic S
Hemoglobin; 2016; 40(1):48-52. PubMed ID: 26575252
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β
Wongborisuth C; Chumchuen S; Sripichai O; Anurathaphan U; Sathirapongsasuti N; Songdej D; Tangprasittipap A; Hongeng S
Sci Rep; 2022 Mar; 12(1):4952. PubMed ID: 35322124
[TBL] [Abstract][Full Text] [Related]
27. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
Ali H; Khan F; Musharraf SG
Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
[TBL] [Abstract][Full Text] [Related]
28. Thalassemia Major and Intermedia Patients in East Java do not Show Fetal Hemoglobin Level Difference in Relation to XMNI Polymorphism.
Wulandari RD; Lyrawati D; Fatchiyah F; Fitri LE
Med Arch; 2020 Apr; 74(2):90-94. PubMed ID: 32577047
[TBL] [Abstract][Full Text] [Related]
29. Transient expression assay of Agamma-588 (A/G) mutations in the K562 cell line.
Hamid M; Mahjoubi F; Akbari MT; Khanahmad H; Jamshidi F; Zeinali S; Karimipoor M
Iran Biomed J; 2011; 15(1-2):15-21. PubMed ID: 21725495
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA
Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846
[TBL] [Abstract][Full Text] [Related]
31. Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.
Dadheech S; Jain S; Madhulatha D; Sharma V; Joseph J; Jyothy A; Munshi A
Mol Biol Rep; 2014 May; 41(5):3331-7. PubMed ID: 24488321
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA HBBP1 enhances γ-globin expression through the ETS transcription factor ELK1.
Ma SP; Xi HR; Gao XX; Yang JM; Kurita R; Nakamura Y; Song XM; Chen HY; Lu DR
Biochem Biophys Res Commun; 2021 May; 552():157-163. PubMed ID: 33744764
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of Greek nondeletional hereditary persistence of fetal hemoglobin and beta-thalassemia compound heterozygotes.
Papadakis MN; Patrinos GP; Tsaftaridis P; Loutradi-Anagnostou A
J Mol Med (Berl); 2002 Apr; 80(4):243-7. PubMed ID: 11976733
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterization of CHD4-associated eRNA as a novel modulator of fetal hemoglobin levels in β-thalassemia.
Jiang Y; Ye Y; Zhang X; Yu Y; Huang L; Bao X; Xu X
Biochem Biophys Res Commun; 2024 Mar; 701():149555. PubMed ID: 38325179
[TBL] [Abstract][Full Text] [Related]
35. South-Italy β°-thalassemia: a novel deletion not removing the γ-globin silencing element and with 3' breakpoint in a hsRTVL-H element, associated with β°-thalassemia and high levels of HbF.
De Angioletti M; Sabato V; Musollino G; Prezioso R; Carestia C; Lacerra G
Haematologica; 2013 Aug; 98(8):e98-e100. PubMed ID: 23812938
[No Abstract] [Full Text] [Related]
36. Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
Zein S; Li W; Ramakrishnan V; Lou TF; Sivanand S; Mackie A; Pace B
Exp Biol Med (Maywood); 2010 Nov; 235(11):1385-94. PubMed ID: 20975082
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of beta thalassemia mutations and HbF levels in the heterozygous Moroccan population.
Lemsaddek W; Picanço I; Seuanes F; Mahmal L; Benchekroun S; Khattab M; Nogueira P; Osório-Almeida L
Am J Hematol; 2003 Jul; 73(3):161-8. PubMed ID: 12827652
[TBL] [Abstract][Full Text] [Related]
38. Frequency of Gγ-globin promoter -158 (C>T) XmnI polymorphism in patients with homozygous/compound heterozygous beta thalassaemia.
Ali N; Ayyub M; Khan SA; Ahmed S; Abbas K; Malik HS; Tashfeen S
Hematol Oncol Stem Cell Ther; 2015 Mar; 8(1):10-5. PubMed ID: 25591326
[TBL] [Abstract][Full Text] [Related]
39. Compound heterozygosity for the Cretan type of non-deletional hereditary persistence of fetal hemoglobin and beta-thalassemia or Hb Sabine confirms the functional role of the Agamma -158 C>T mutation in gamma-globin gene transcription.
Kollia P; Kalamaras A; Chassanidis C; Samara M; Vamvakopoulos NK; Radmilovic M; Pavlovic S; Papadakis MN; Patrinos GP
Blood Cells Mol Dis; 2008; 41(3):263-4. PubMed ID: 18718799
[No Abstract] [Full Text] [Related]
40. PUM1 mediates the posttranscriptional regulation of human fetal hemoglobin.
Elagooz R; Dhara AR; Gott RM; Adams SE; White RA; Ghosh A; Ganguly S; Man Y; Owusu-Ansah A; Mian OY; Gurkan UA; Komar AA; Ramamoorthy M; Gnanapragasam MN
Blood Adv; 2022 Dec; 6(23):6016-6022. PubMed ID: 35667093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
